I think one of the reason for the EU’s demand for UK AZ vaccines is that AZ’s contract with the EU specifies that all vaccines will be manufactured in the EU, but includes provision for them to be supplied from elsewhere, including the UK, under certain circumstances. An additional complication is that, whereas AZ has to seek permission from the EU to supply from other countries, the UK is exempt from this provision, which could suggest that the UK is being treated as more equivalent to an EU based supplier. Hence, when AZ couldn’t meet expectations from its EU-based facilities, the EU demanded that it make up the shortfall from its UK facilities.Saint wrote: ↑Tue Apr 13, 2021 7:54 pmWell, that's never really been explained. But Pfizer themselves have pointed out to the EU that if the EU blocks exports to the UK then the UK's natural reaction might be to shit down component export to Pfizer. The thing about mRNA vaccines is that they;re close to being synthetic (predictable) production process rather than a biological (unpredictable) process, but for the moment at least they require complex supply chains involving many countries, unless you're the size of the US. Curevac mRNA when it comes online will be an mRNA completely manufactured in the UK AFAIK.
The UK doesn’t manufacture the Pfizer vaccine so they can’t really demand we supply these. When the EU first passed its laws restricting vaccine exports, there was an expectation that they might halt Pfizer vaccines as well, but Pfizer very quickly informed the German govt of the implications of doing this, and so Pfizer was quickly put off limits for these controls.